Back
42
Also listed as
AXFOF
OTC
Day Range
$27.24
$27.24
52-Week Range
$25.22
$27.24
Volume
100
50D / 200D Avg
$27.24
/
$27.05
Prev Close
$27.24
Price History
Financial Trends
Peer Comparison
vs Consumer Defensive sector median (329 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 2.5 | 10.4 |
| P/B | 0.8 | 1.2 |
| ROE % | 32.1 | 12.6 |
| Net Margin % | 2.6 | 5.3 |
| Rev Growth 5Y % | 11.4 | 5.5 |
| D/E | 2.1 | 0.6 |
Key Takeaways
Revenue grew 11.40% annually over 5 years — strong growth
ROE of 32.13% indicates high profitability
Debt/Equity of 2.05 — high leverage
Generating 5.05B in free cash flow
P/E of 2.51 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 5.34%
Growth
Revenue Growth (5Y)
11.40%
Revenue (1Y)6.06%
Earnings (1Y)6.71%
FCF Growth (3Y)14.36%
Quality
Return on Equity
32.13%
ROIC11.69%
Net Margin2.62%
Op. Margin4.01%
Safety
Debt / Equity
2.05
Current Ratio0.71
Interest Coverage6.17
Valuation
P/E Ratio
2.51
P/B Ratio0.78
EV/EBITDA5.66
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.06% | Revenue Growth (3Y) | 4.84% |
| Earnings Growth (1Y) | 6.71% | Earnings Growth (3Y) | -0.38% |
| Revenue Growth (5Y) | 11.40% | Earnings Growth (5Y) | 2.13% |
| Profitability | |||
| Revenue (TTM) | 89.15B | Net Income (TTM) | 2.34B |
| ROE | 32.13% | ROA | 6.34% |
| Gross Margin | 14.73% | Operating Margin | 4.01% |
| Net Margin | 2.62% | Free Cash Flow (TTM) | 5.05B |
| ROIC | 11.69% | FCF Growth (3Y) | 14.36% |
| Safety | |||
| Debt / Equity | 2.05 | Current Ratio | 0.71 |
| Interest Coverage | 6.17 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | 2.51 | P/B Ratio | 0.78 |
| P/S Ratio | 0.07 | PEG Ratio | 3.46 |
| EV/EBITDA | 5.66 | Dividend Yield | 0.03% |
| Market Cap | 5.88B | Enterprise Value | 20.21B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 89.15B | 84.06B | 81.11B | 73.47B | 57.89B |
| Net Income | 2.34B | 2.19B | 2.36B | 2.36B | 2.15B |
| EPS (Diluted) | 10.79 | 10.11 | 10.87 | 11.03 | 10.16 |
| Gross Profit | 13.13B | 12.23B | 11.33B | 10.08B | 8.95B |
| Operating Income | 3.57B | 3.29B | 3.35B | 3.10B | 2.70B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 36.91B | 35.43B | 30.02B | 28.62B | 23.73B |
| Total Liabilities | 29.08B | 28.04B | 22.83B | 21.72B | 18.56B |
| Shareholders' Equity | 7.51B | 7.05B | 6.88B | 6.61B | 4.95B |
| Total Debt | 15.40B | 15.30B | 9.76B | 9.25B | 8.00B |
| Cash & Equivalents | 1.08B | 735.00M | 688.00M | 559.00M | 734.00M |
| Current Assets | 9.89B | 8.81B | 8.85B | 8.46B | 7.51B |
| Current Liabilities | 13.92B | 13.17B | 13.72B | 12.74B | 12.06B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#217 of 658
Recent Activity
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026